γ-Hydroxybutyric acid is a well-known prescription medicine that is used for the clinical treatment of alcohol dependence and narcolepsy. However, the biochemical mechanism underlying γ-hydroxybutyric acid intoxication remains unclear, and metabolomic amino acid profiling and pattern analyses have not been attempted following treatment with γ-hydroxybutyric acid.
We carried out urinary amino acid profiling and pattern analyses in rats to determine the biochemical events associated with altered amino acid metabolism and biomarker detection of intoxication following treatment with γ-hydroxybutyric acid.
Metabolic profiling analysis of amino acids in rat urine samples was performed as ethoxycarbonyl/tert-butyldimethylsilyl derivatives by gas chromatography–mass spectrometry following intraperitoneal administration of γ-hydroxybutyric acid once per day for 1 and 10 consecutive days.
A total of 28 amino acids were positively identified in urine samples from the control, single and multiple groups treated with γ-hydroxybutyric acid. Their levels from the single and multiple treated groups were normalized to the corresponding mean control values. The star graphic pattern of the amino acids was characteristic and readily distinguishable for each group owing to its distorted nonacosagonal shape. In the principle component analysis, we monitored phenylalanine, glutamic acid, aspartic acid, asparagine, and methionine as contributing factors that discriminated the three groups.
The present metabolomic study may explain the altered metabolism of amino acids following administration, and intoxication with γ-hydroxybutyric acid.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Black, J., Pardi, D., Hornfeldt, C. S., & Inhaber, N. (2009). The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Sleep Medicine, 10, 829–835. https://doi.org/10.1016/j.sleep.2009.05.004.
Busardò, F. P., & Jones, A. W. (2015). GHB pharmacology and toxicology: Acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Current Neuropharmacology, 13(1), 47–70. https://doi.org/10.2174/1570159X13666141210215423.
Carter, L. P., Koek, W., & France, C. P. (2009). Behavioral analyses of GHB: Receptor mechanisms. Pharmacology and Therapeutics, 121(1), 100–114. https://doi.org/10.1016/j.pharmthera.2008.10.003.
Felmlee, M. A., Roiko, S. A., Morse, B. L., & Morris, M. E. (2010). Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid. Journal of Pharmacology and Experimental Therapeutics, 333, 764–771. https://doi.org/10.1124/jpet.109.165381.
Gobaille, S., Schleef, C., Hechler, V., Viry, S., Aunis, D., & Maitre, M. (2002). Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. Life Science, 70, 2101–2112. https://doi.org/10.1016/S0024-3205(01)01526-0.
Kam, P. C., & Yoong, F. F. (1998). Gamma-hydroxybutyric acid: An emerging recreational drug. Anaesthesia, 53, 1195–1198. https://doi.org/10.1046/j.1365-2044.1998.00603.x.
Kapoor, P., Deshmukh, R., & Kukreja, I. (2013). GHB acid: A rage or reprive. Journal of Advanced Pharmaceutical Technology & Research, 4, 173–178. https://doi.org/10.4103/2231-4040.121410.
Kim, H. B., Seo, C., Kim, Y. B., Na, M. J., Kang, J. S., Lee, W. J., & Paik, M. J. (2016). Simultaneous urinary creatine and creatinine analysis by high performance liquid chromatography. Bulletin of the Korean Chemical Society, 37, 756–758. https://doi.org/10.1002/bkcs.10743.
Kim, J. W., Lee, G., Moon, S. M., Park, M. J., Hong, S. K., Ahn, Y. H., Kim, K. R., & Paik, M. J. (2010). Metabolomic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patients. Metabolomics, 6, 202–206. https://doi.org/10.1007/s11306-010-0199-6.
Kim, S. Y., Anderson, I. B., Dyer, J. E., Barker, J. C., & Blanc, P. D. (2007). High-risk behaviors and hospitalizations among gamma-hydroxybutyrate (GHB) users. The American Journal of Drug and Alcohol Abuse, 33, 429–438. https://doi.org/10.1080/00952990701312316.
Marcello, V., Giuseppe, D. G., & Vincenzo, C. (2014) A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures. CNS Neuroscience & Therapeutics, 21, 123–140. https://doi.org/10.1111/cns.12337.
Michel, M. (1997). The γ-hydroxybutyrate signaling system in brain: Organization and functional implications. Progress in Neurobiology, 51, 337–361. https://doi.org/10.1016/S0301-0082(96)00064-0.
Paik, M. J., Lee, H. J., & Kim, K. R. (2005). Simultaneous retention index analysis of urinary amino acids and carboxylic acids for graphic recognition of abnormal state. Journal of Chromatography. 821, 94–104. https://doi.org/10.1016/j.jchromb.2005.04.011
Paik, M. J., Li, W. Y., Ahn, Y. H., Lee, P. H., Choi, S., Kim, K. R., et al. (2009). The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats. Clinica Chimica Acta; International Journal of Clinical Chemistry, 402, 25–30. https://doi.org/10.1016/j.cca.2008.12.022.
Paik, M. J., Moon, S. M., Kim, K. R., Choi, S. D., Ahn, Y. H., & Lee, G. (2008). Target metabolic profiling analysis of free amino acids in plasma as EOC/TBDMS derivatives by GC-SIM-MS. Biomedical Chromatography, 22, 339–342. https://doi.org/10.1002/bmc.939.
Seo, C., Hwang, Y. H., Kim, Y., Joo, B. S., Yee, S. T., Kim, C. M., & Paik, M. J. (2016b). Metabolomic study of aging in mouse plasma by gas chromatography-mass spectrometry. Journal of Chromatography B, 1025, 1–6. https://doi.org/10.1016/j.jchromb.2016.04.052.
Seo, C., Park, M., Choi, B., Lee, S., & Paik, M. J. (2016a). Metabolomic analysis of urinary organic acids following intraperitoneal injection with γ-hydroxybutyric acid in rats. Metabolomics, 12(190), 1–9. https://doi.org/10.1007/s11306-016-1125-3.
Shim, W., Paik, M. J., Nguyen, D. T., Lee, J. K., Lee, Y., Kim, J. H., et al. (2012). Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles. ACS Nano, 6(9), 7665–7680. https://doi.org/10.1021/nn301113f.
Stillwell, M. E. (2002). Drug-facilitated sexual assault involving γ-hydroxybutyric acid. Journal of Forensic Science, 47, 1133–1134. https://doi.org/10.1520/JFS15523J.
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1A6A1A03011325), by the Ministry of Science, ICT & Future Planning (2015R1A4A1041219) and by Suncheon Research Center for Natural Medicines.
Conflict of interest
The authors declare no conflicts of interest.
All procedures performed in studies involving animals were in accordance with the ethical standards of the National Forensic Service.
About this article
Cite this article
Seo, C., Na, M., Jang, J. et al. Monitoring of altered amino acid metabolic pattern in rat urine following intraperitoneal injection with γ-hydroxybutyric acid. Metabolomics 14, 111 (2018). https://doi.org/10.1007/s11306-018-1409-x
- γ-Hydroxybutyric acid
- Amino acid profiling analysis
- Star pattern analysis
- Gas chromatography–mass spectrometry